J. Vardiman

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

H. Muller-Hermelink, Jacques Diebold, Georges Flandrin, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes.

J. Vardiman, J. Dickstein, James W. Vardiman, 1993, American journal of clinical pathology.

Issues in the pathology of the myelodysplastic syndromes.

J. Vardiman, J. Anastasi, P. Kampmeier, 1992, Hematology/oncology clinics of North America.

Pomalidomide is active in the treatment of anemia associated with myelofibrosis.

H. Deeg, H. Kantarjian, S. Verstovsek, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphoma: A Single Disease With Multiple Variants

B. Bellosillo, J. Gil, Beatriz Bellosillo, 1999 .

Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.

J. Diebold, N. Harris, H. Müller-Hermelink, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies.

M. Ratain, R. Larson, L. Platanias, 1994, Leukemia & lymphoma.

Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia

C. Bloomfield, M. Cazzola, M. L. Beau, 2016 .

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

Sa A Wang, D. Arber, M. Borowitz, 2017, Archives of pathology & laboratory medicine.

Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.

J. Vardiman, R. Mick, R. Spielberger, 1994, Blood.